1

2

3
Breitenstein Werner, Ehara Takeru, Ehrhardt Claus, Grosche Philipp, Hitomi Yuko, Iwaki Yuki, Kanazawa Takanori, Konishi Kazuhide, Maibaum Juergen Klaus, Masuya Keiichi, Nihonyanagi Atsuko, Ostermann Nils, Suzuki Masaki, Toyao Atsushi, Yokokawa Fumiaki: Organic compounds. Novartis, Novartis Pharma, Breitenstein Werner, Ehara Takeru, Ehrhardt Claus, Grosche Philipp, Hitomi Yuko, Iwaki Yuki, Kanazawa Takanori, Konishi Kazuhide, Maibaum Juergen Klaus, Masuya Keiichi, Nihonyanagi Atsuko, Ostermann Nils, Suzuki Masaki, Toyao Atsushi, Yokokawa Fumiaki, sHILLEBRAND Dirk, July 6, 2006: WO/2006/069788 (19 worldwide citation)

3,4-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (= disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical fo ...


4

5

6
Ehara Takeru, Grosche Philipp, Irie Osamu, Iwaki Yuki, Kanazawa Takanori, Kawakami Shimpei, Konishi Kazuhide, Mogi Muneto, Suzuki Masaki, Yokokawa Fumiaki: 3 , 5-substit&ggr;ued piperidine compounds as renin inhibitors. Novartis, Ehara Takeru, Grosche Philipp, Irie Osamu, Iwaki Yuki, Kanazawa Takanori, Kawakami Shimpei, Konishi Kazuhide, Mogi Muneto, Suzuki Masaki, Yokokawa Fumiaki, DIETEL Anja, July 12, 2007: WO/2007/077005 (10 worldwide citation)

The invention relates to 3,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (= disorder) that depends on activity of renin; the use of a compound of that class for the preparati ...


7
Masuya Keiichi, Yokokawa Fumiaki, Irie Osamu, Nihonyanagi Atsuko, Toyao Atsushi, Ehara Takeru, Konishi Kazuhide, Kanazawa Takanori, Suzuki Masaki: 3,4,5-substituted piperidine compounds. Novartis, Novartis Pharma, Masuya Keiichi, Yokokawa Fumiaki, Irie Osamu, Nihonyanagi Atsuko, Toyao Atsushi, Ehara Takeru, Konishi Kazuhide, Kanazawa Takanori, Suzuki Masaki, GRUBB Philip, September 14, 2006: WO/2006/094763 (8 worldwide citation)

3,4,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (= disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical ...


8

9
Masuya Keiichi, Irie Osamu, Nihonyanagi Atsuko, Toyao Atsushi, Kanazawa Takanori: 3,4,(5)-substituted tetrahvdropyridines. Novartis, Novartis Pharma, Masuya Keiichi, Irie Osamu, Nihonyanagi Atsuko, Toyao Atsushi, Kanazawa Takanori, sDE WEERD Peter, July 20, 2006: WO/2006/074924 (4 worldwide citation)

Organic Compounds 3,4(,5)-substituted tetrahydropyridine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease that depends on activity of renin; the use of a compound of that class for the preparation of a ...


10
Garcia Echeverria Carlos, Kanazawa Takanori, Kawahara Eiji, Masuya Keiichi, Matsuura Naoko, Miyake Takahiro, Ohmori Osamu, Umemura Ichiro, Steensma Ruo, Chopiuk Greg, Jiang Jiqing, Wan Yongqin, Ding Qiang, Zhang Qiong, Gray Nathanael Schiander, Karanewsky Donald: 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders. Novartis, Irm, May 9, 2006: KR1020067003056 (1 worldwide citation)

Novel pyrimidine derivatives of formula (I) Wherein R is selected from C16-10 aryl, C5-10heteroaryl, C3-12cycloalkyl and C3- 10heterocycloalkyl; R0-R6 as described herein; and their use for the manufacture of a medicament for the treatment or prevention of a disease wich responds to inhibition of FA ...